FNSR News and Press, Finisar Corporation From 09/05/19

Last monthly update, I exited the Finisar ( FNSR ) position, which is being acquired by II-VI ( IIVI ) because spreads tightened on the Cisco ( CSCO ) and Acacia ( ACIA ) deal (which I reviewed here ). The China risk did not diminish on that deal. I don't understand why the spread would tight...

Finisar (NASDAQ: FNSR ) fell short with fiscal Q1 earnings as revenues dropped by double digits. More news on: Finisar Corporation, II-VI Incorporated, Tech stocks news, Earnings news and commentary Read more ...

Finisar (NASDAQ: FNSR ): Q1 Non-GAAP EPS of $0.23 misses by $0.02 ; GAAP EPS of -$0.07 misses by $0.03 . More news on: Finisar Corporation, Earnings news and commentary, Tech stocks news, Read more ...

SUNNYVALE, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Finisar Corporation (NASDAQ: FNSR), a global technology leader for subsystems and components for fiber optic communications, today announced financial results for its first quarter of fiscal 2020, ended July 28, 2019. Finisar will not ho...

SUNNYVALE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Finisar (NASDAQ: FNSR) today introduced its WaveAnalyzer™ 1500S/L High Resolution Optical Spectrum Analyzer designed to inspect the spectral characteristics of optical channels in the L-band of the telecommunications spectrum. Thi...

Introduction We present here some results of a study on U.S. listed companies in the healthcare sector (Nasdaq, NYSE and Amex) based on their patent activity, in particular derived from PCT (Patent Cooperation Treaty) patent applications administered by the World Intellectual Property Offi...

II-VI (NASDAQ: IIVI )  dips 1.4% after Q4 beats with the news that the company will have to refile for Finisar (NASDAQ: FNSR ) acquisition approval in China. More news on: II-VI Incorporated, Finisar Corporation, Tech stocks news, Stocks on the move, Earnings news and comme...

Merger activity decreased last week with three new deals announced and ten pending deals closing. Deal Statistics: New Deals: The acquisition of Genomic Health ([[GHDX]]) by Exact Sciences Corporation ([[EXAS]]) for $2.8 billion in a cash-plus-stock deal. Under the terms of the ...

Finisar (NASDAQ: FNSR ) CEO Michael Hurlston has informed the board he'll resign to pursue another opportunity. More news on: Finisar Corporation, II-VI Incorporated, Tech stocks news Read more ...

SUNNYVALE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Finisar Corporation (NASDAQ: FNSR), a global technology leader for subsystems and components for fiber optic communications, today announced that its Chief Executive Officer, Michael Hurlston, has informed the Board of Directors of his in...